Stroma in tumors forms a barrier to immunity against cancer. New findings show that stimulating both stroma and T lymphocytes together leads to potent immunity against established tumors.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Dvorak, H.F. N. Engl. J. Med. 315, 1650–1659 (1986).
Yu, P. et al. Nat. Immunol. 5, 141–149 (2004).
Singh, S., Ross, S.R., Acena, M., Rowley, D.A. & Schreiber, H. J. Exp. Med. 175, 139–146 (1992).
Perdrizet, G.A. et al. J. Exp. Med. 171, 1205–1220 (1990).
Wick, M. et al. J. Exp. Med. 186, 229–238 (1997).
Groh, V., Wu, J., Yee, C. & Spies, T. Nature 419, 734–738 (2002).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Houghton, A. LIGHTing the way for tumor immunity. Nat Immunol 5, 123–124 (2004). https://doi.org/10.1038/ni0204-123
Issue Date:
DOI: https://doi.org/10.1038/ni0204-123